Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03153696 · ClinicalTrials.gov registry record · NA

Initial Evaluation of the Cellie Coping Kit for Children With Injury

A NA study of Injuries, sponsored by Meghan Marsac.

Completed
Registry status
NA
Development phase
94
Enrollment target
1
Study location

NCT03153696: Completed NA study of Injuries, sponsored by Meghan Marsac.

NCT03153696 is a NA study of Injuries that has completed, run by Meghan Marsac. The registered enrollment target is 94 participants, below the 1,618-participant average among 6 other Injuries trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03153696, a NA study of Injuries, has completed, sponsored by Meghan Marsac.

COMPLETED
Registry status
NA
Development phase
94 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the feasibility (fidelity, acceptability, implementation, cost) of the Cellie Coping Kit for Children with Injury as well as to determine the intervention's efficacy (mechanisms of action and health outcomes).

Primary Outcome

Feasibility will be primarily assessed via a self-report satisfaction score.

Conditions Studied

Interventions

  • BEHAVIORAL Cellie Coping Kit Intervention

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2017-08-01
Est. Completion 2019-12-02
Phase NA
Meghan Marsac

1 total trials

What the finished NCT03153696 record still lists

NCT03153696 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 1,618-participant average among 6 other Injuries trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Injuries appearing as the primary indexed condition, and to 1 intervention - of which Cellie Coping Kit Intervention is the first listed.

NCT03153696 reports a single indexed study location in Kentucky.

Frequently Asked Questions

What is clinical trial NCT03153696 about?

NCT03153696 is a clinical study titled "Initial Evaluation of the Cellie Coping Kit for Children With Injury". The purpose of this study is to assess the feasibility (fidelity, acceptability, implementation, cost) of the Cellie Coping Kit for Children with Injury as well as to determine the intervention's efficacy (mechanisms of action and health outcomes).

What is the current status of trial NCT03153696?

This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2017-08-01. Estimated completion is 2019-12-02.

What conditions does trial NCT03153696 study?

This clinical trial studies the following conditions: Injuries.

What interventions are being tested in trial NCT03153696?

The interventions under investigation include: Cellie Coping Kit Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03153696?

This trial is sponsored by Meghan Marsac, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03153696 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03747146 · 94 participants · NA

    Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service

  • NCT04061421 · 94 participants · Phase 1

    Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)

  • NCT04205968 · 94 participants · Phase 2

    Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

  • NCT04464759 · 94 participants · Phase 1

    A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03153696, the US trial registry maintained by the National Library of Medicine. NCT03153696 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.